ATTR-CM (transthyretin amyloid cardiomyopathy) is a rare condition that causes a range of vague symptoms, including shortness ...

La Commissione Europea (CE) ha approvato il farmaco vutrisiran per il trattamento di pazienti adulti con cardiomiopatia ...

Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.

The Inflation Reduction Act includes an exemption for orphan drugs for a single indication, but experts say this is far from ...

Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.

The approach could enable 30-minute testing for a heart condition that is newly treatable following recent drug approvals.

Alnylam Pharmaceuticals named Pushkal Garg executive vice president and chief research and development officer. The company said Wednesday that Garg will help oversee an integrated R&D organization to ...

Alnylam Pharmaceuticals , leader nelle terapie di interferenza dell’RNA (RNAi), si sta posizionando per una crescita significativa con la recente approvazione e lancio del suo farmaco Amvuttra per il ...

Alnylam Pharmaceuticals , a leader in RNA interference (RNAi) therapeutics, is positioning itself for significant growth with the recent approval and launch of its drug Amvuttra for the treatment of ...

Alnylam Pharmaceuticals , a leader in RNA interference (RNAi) therapeutics, is positioning itself for significant growth with the recent approval and launch of its drug Amvuttra for the treatment of ...